Other Names: Pseudobutyrivibrio Pseudobutyrivibrio van Gylswyk et al. 1996
Change Display Name to
Desired Levels from Some Experts
Ranges can vary from lab to lab because of different equipment and software being used.
Possible Health Impacts
I would like to know about this bacteria's
Citizen Science 2.0 Explorer. List is restricted to associations with a high count and a change of random occurance greater than 1 in 100.
|Asymptomatic: Minor Health Issues (a few symptoms only)||Between 50%ile to 100%ile||1 to 18824.8|
|Neurological: Short-term memory issues||Between 50%ile to 100%ile||1 to 7080.8|
|Neurological: Short-term memory issues||Between 66%ile to 100%ile||1 to 4493.5|
|Neurological: Difficulty processing information (Understanding)||Between 66%ile to 100%ile||1 to 2243.5|
|Neurological: Difficulty processing information (Understanding)||Between 50%ile to 100%ile||1 to 1922.2|
|Neuroendocrine Manifestations: Dry Eye (Sicca or Sjogren Syndrome)||Between 50%ile to 100%ile||1 to 1029.1|
|Asymptomatic: No Health Issues||Between 50%ile to 100%ile||1 to 662.1|
|Autonomic Manifestations: urinary frequency dysfunction||Between 50%ile to 100%ile||1 to 632.3|
|Immune Manifestations: new food sensitivities||Between 50%ile to 100%ile||1 to 567.6|
|Functional constipation / chronic idiopathic constipation||High||1|
|rheumatoid arthritis (RA),Spondyloarthritis (SpA)||Low||1|
|Systemic Lupus Erythematosus||Low||1|
A P-value below 0.0001 is the recommended threshold. A larger R-Square value means a stronger relationship. This is unpublished data using Properitary Artificial Intelligence.